FDA Investigator Lydia I Rosas Marty

Lydia I Rosas Marty has conducted inspections on 19 sites in 8 countries as of 24 Jun 2013. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
19
Last Inspection Date:
24 Jun 2013
Investigator Role:
FDA Investigator
Redica ID:
100000070
Countries of Inspections:
Netherlands, Germany, Spain, Italy, United Kingdom of Great Britain and Northern Ireland, Denmark, Brazil, Canada
FDA Investigators that have inspected at least one site in common with Lydia I Rosas Marty:
Angela E Glenn, Anissa M Vargas, Ann Marie Montemurro, Ann Marie Schofield, Anthony F Lorenzo, Ashley J Burns, Azza Talaat, Brian D Nicholson, Carla A Norris, Carla J Lundi, Caryn M Mcnab, CDR Ileana Barreto Pettit, Charisse K Green, Charles M Edwards, Charles R Cote, RIC, Christine W Twohy, Christopher T Middendorf, Christopher T Peters, Cynthia Jim, CSO, Daniel J Grabicki, David A Oluwo, David J Gomes, Deborah A Greco, Dell S Moller, Demitria J Xiradakis, Denise M Digiulio, Dennis Cantellops Paite, Don H Bark, PhD, Dongping Dai, PhD, Douglas A Campbell, Douglas C Kovacs, Dr. Barbara D Paul, PhD, Edmund F Mrak, Jr, Emest F Bizjak, Erin C Hill, Felix Maldonado, Frederick F Razzaghi, German Rivera, Ginger M Sykes, Grace E Mcnally, Gwyn G Dickinson, Helen B Ricalde, Ivis L Negron, Jacob G Lutz, James L Dunnie, Jr, Joanne E King, Joel D Hustedt, Joey V Quitania, John P Mistler, Jose Acruz Gonzalez, Joshua P Wireman, Junho Pak, Karen E D'orazio, Katherine D Adams, Kenneth H Williams, Kenneth M Gordon, Kevin A Gonzalez, Kevin D Kallander, Kham Phommachanh, Larry K Austin, Laura S Huffman, Lawrence J Stringer, LCDR Chad N Thompson, LCDR Debra Emerson, LCDR Michael H Tollon, Linda K Cline, Lisa Hornback, Luis Mburgos Medero, Marie F Morin, Mariza M Jafary, Megan A Haggerty, Melissa J Garcia, Meyer J Slobotsky, Michael A Charles, Michael E Maselli, Michael P Sheehan, Michael R Goga, Miguel A Martinez Perez, Mikhail V Ovanesov, PhD, Minh D Phan, Mra B Kamberem, Mra Davism, Mra Mcculloughj, Nancy A Saxenian Emmons, Nancy G Schmidt, Nancy L Rolli, Nicholas L Paulin, Omotunde O Osunsanmi, Pankaj H Amin, Parul M Patel, Paul L Bellamy, Paula A Trost, Prabhu P Raju, Ramon E Martinez, Raymond T Oji, Regina T Brown, Robert J Doyle, Russell J Glapion, Russell K Riley, Samantha J Bradley, Sandra A Hughes, Scott T Ballard, Sergey S Akimov, Sharon K Thoma, PharmD, Simone E Pitts, Stacie A Woods, Stephen D Brown, Stephen D Eich, Steven M Weinman, Susan M Jackson, Susan T Hadman, Susanna E Ford, Temar Q Williams, Thomas J Arista, Tina M Pawlowski, Tonya R Johnson, Torrance J Slayton, Uduak M Inokon, Unnee Ranjan, Viviana R Ramirez, Yumi J Hiramine, Yvesna C Blaise

Lydia I Rosas Marty's Documents

Publish Date Document Type Title
October, 2003 FDA 483 Response Catalent Anagni S.R.L. - Form 483R, 2003-12-10
October, 2001 EIR Takeda GmbH - EIR, 2001-10-17
October, 2001 FDA 483 Takeda GmbH - Form 483, 2001-10-17
May, 2001 EIR CP Pharmaceuticals Ltd - EIR, 2001-08-14
October, 2003 EIR Sicor Societa' Italiana Corticosteroidi s.r.l - EIR, 2003-11-26
October, 2002 EIR DMV International - EIR, 2002-10-17
October, 2003 EIR Catalent Anagni S.R.L. - EIR, 2003-11-26
October, 2003 EIR Sicor Societa' Italiana Corticosteroidi s.r.l - EIR, 2003-11-26
May, 2001 FDA 483 CP Pharmaceuticals Ltd - Form 483, 2001-05-25
October, 2003 FDA 483 Response Sicor Societa' Italiana Corticosteroidi s.r.l - Form 483R, 2003-12-10
October, 2002 FDA 483 Response DMV International - Form 483R, 2002-10-31
May, 2001 FDA 483 Response CP Pharmaceuticals Ltd - Form 483R, 2001-06-08
October, 2002 FDA 483 DMV International - Form 483, 2002-10-17
October, 2001 FDA 483 Response Takeda GmbH - Form 483R, 2001-12-14
October, 2003 FDA 483 Response Sicor Societa' Italiana Corticosteroidi s.r.l - Form 483R, 2003-12-10

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more